These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37944649)

  • 61. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression.
    Sun Y; Jin SD; Zhu Q; Han L; Feng J; Lu XY; Wang W; Wang F; Guo RH
    Oncotarget; 2017 Apr; 8(17):28297-28311. PubMed ID: 28423699
    [TBL] [Abstract][Full Text] [Related]  

  • 63. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
    Zhang M; Xu Y; Yin S; Qiu F
    Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
    Han Z; Shi L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p.
    Yang T; Xia S
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207530
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.
    Min J; Ma J; Wang Q; Yu D
    Clinics (Sao Paulo); 2022; 77():100081. PubMed ID: 36087568
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response.
    Huan L; Guo T; Wu Y; Xu L; Huang S; Xu Y; Liang L; He X
    Mol Cancer; 2020 Jan; 19(1):11. PubMed ID: 31964396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
    Xiang X; Guo Y; Chen Z; Zhang F; Huang J; Qin Y
    Medicine (Baltimore); 2022 Dec; 101(51):e32558. PubMed ID: 36595859
    [TBL] [Abstract][Full Text] [Related]  

  • 69. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
    Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
    J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
    [TBL] [Abstract][Full Text] [Related]  

  • 70. BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.
    Liu SC; Cao YH; Chen LB; Kang R; Huang ZX; Lu XS
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 35998226
    [TBL] [Abstract][Full Text] [Related]  

  • 71. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
    Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
    Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
    Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
    Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
    [No Abstract]   [Full Text] [Related]  

  • 73. Downregulated long noncoding RNA LUCAT1 inhibited proliferation and promoted apoptosis of cardiomyocyte via miR-612/HOXA13 pathway in chronic heart failure.
    Li T; Qian D; Guoyan J; Lei Z
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):385-395. PubMed ID: 31957853
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma.
    Lou Y; Yu Y; Xu X; Zhou S; Shen H; Fan T; Wu D; Yin J; Li G
    J Cell Mol Med; 2019 Mar; 23(3):1873-1884. PubMed ID: 30588744
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Up-regulated lnc-lung cancer associated transcript 1 enhances cell migration and invasion in breast cancer progression.
    Li YL; Wang XM; Qiao GD; Zhang S; Wang J; Cong YZ; Zhu SG
    Biochem Biophys Res Commun; 2020 Jan; 521(2):271-278. PubMed ID: 31635802
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Upregulation of Long Noncoding RNA TUG1 Promotes Bladder Cancer Cell Proliferation, Migration, and Invasion by Inhibiting miR-29c.
    Guo P; Zhang G; Meng J; He Q; Li Z; Guan Y
    Oncol Res; 2018 Aug; 26(7):1083-1091. PubMed ID: 29321088
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
    Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
    Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
    [TBL] [Abstract][Full Text] [Related]  

  • 78. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 79. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
    Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
    J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
    [TBL] [Abstract][Full Text] [Related]  

  • 80. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
    Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
    BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.